Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab

<i>Background</i>: We aimed to assess the clinical utility of a previously published score combining the total metabolic tumor volume (TMTV) on baseline FDG-PET/CT and pretreatment derived from the neutrophils to lymphocytes ratio (dNLR) for prognostication in NSCLC patients undergoing f...

Full description

Bibliographic Details
Main Authors: Romain-David Seban, Jean-Baptiste Assié, Etienne Giroux-Leprieur, Marie-Ange Massiani, Michael Soussan, Gérald Bonardel, Christos Chouaid, Margot Playe, Lucas Goldfarb, Boris Duchemann, Laura Mezquita, Nicolas Girard, Laurence Champion
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
FDG-PET
NSCLC
first-line immunotherapy
derived neutrophils to lymphocytes ratio
total metabolic tumor volume
prognosis
Online Access:https://www.mdpi.com/2072-6694/12/8/2234

Internet

https://www.mdpi.com/2072-6694/12/8/2234

Similar Items